II-VI Incorporated (IIVI) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of II-VI Incorporated (NASDAQ:IIVI) from a sell rating to a buy rating in a report published on Friday morning. The firm currently has $47.00 target price on the scientific and technical instruments company’s stock.

According to Zacks, “II-VI Incorporated designs, manufactures and markets optical and opto-electronic components, devices and materials for infrared, near-infrared, visible light, x-ray and gamma ray instrumentation. The Company’s infrared optics business manufactures optical and opto-electronic components sold under the II-VI brand name and used primarily in CO2 lasers. The Company’s near-infrared optics business manufactures near-infrared & visible light products for industrial, scientific, military & medical instruments and laser gain materials and products for solid-state YAG and YLF lasers at the Company’s VLOC subsidiary. The Company’s military infrared optics business manufactures infrared products for military applications under the Exotic Electro-Optics brand name. “

Other research analysts have also recently issued reports about the stock. B. Riley reiterated a neutral rating and set a $39.50 target price on shares of II-VI in a report on Thursday, August 10th. Northland Securities assumed coverage on shares of II-VI in a report on Thursday, July 6th. They set an outperform rating and a $45.00 target price on the stock. Needham & Company LLC reiterated a buy rating and set a $50.00 target price (up from $45.00) on shares of II-VI in a report on Wednesday, November 1st. BidaskClub lowered shares of II-VI from a buy rating to a hold rating in a research report on Monday, July 31st. Finally, Craig Hallum began coverage on shares of II-VI in a research report on Monday, July 24th. They set a buy rating and a $50.00 price target for the company. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and six have assigned a buy rating to the company’s stock. The stock presently has an average rating of Buy and a consensus target price of $48.75.

II-VI (IIVI) opened at $41.50 on Friday. The company has a quick ratio of 2.63, a current ratio of 3.89 and a debt-to-equity ratio of 0.43. The company has a market cap of $2,619.84, a PE ratio of 25.00 and a beta of 0.02. II-VI has a 1-year low of $26.70 and a 1-year high of $46.50.

II-VI (NASDAQ:IIVI) last issued its earnings results on Tuesday, October 31st. The scientific and technical instruments company reported $0.32 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.36 by ($0.04). II-VI had a return on equity of 12.25% and a net margin of 9.89%. The business had revenue of $261.50 million for the quarter, compared to the consensus estimate of $255.20 million. During the same quarter in the previous year, the company earned $0.35 earnings per share. The firm’s revenue was up 18.1% on a year-over-year basis. research analysts predict that II-VI will post 1.55 EPS for the current year.

WARNING: “II-VI Incorporated (IIVI) Upgraded at Zacks Investment Research” was first reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this article on another website, it was copied illegally and reposted in violation of international copyright legislation. The original version of this article can be read at https://www.com-unik.info/2017/11/06/ii-vi-incorporated-iivi-upgraded-at-zacks-investment-research.html.

In related news, CFO Mary Jane Raymond sold 1,000 shares of the stock in a transaction that occurred on Tuesday, October 31st. The shares were sold at an average price of $45.00, for a total value of $45,000.00. Following the completion of the transaction, the chief financial officer now directly owns 53,415 shares of the company’s stock, valued at approximately $2,403,675. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Francis J. Kramer sold 25,000 shares of the stock in a transaction that occurred on Monday, October 2nd. The shares were sold at an average price of $42.00, for a total transaction of $1,050,000.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 51,000 shares of company stock valued at $2,222,500. Insiders own 3.80% of the company’s stock.

Several institutional investors have recently made changes to their positions in IIVI. BlackRock Inc. raised its position in shares of II-VI by 55,200.0% in the 1st quarter. BlackRock Inc. now owns 6,752,130 shares of the scientific and technical instruments company’s stock valued at $243,415,000 after purchasing an additional 6,739,920 shares during the last quarter. Vanguard Group Inc. raised its position in shares of II-VI by 10.0% in the 1st quarter. Vanguard Group Inc. now owns 4,959,583 shares of the scientific and technical instruments company’s stock valued at $178,793,000 after purchasing an additional 450,482 shares during the last quarter. State Street Corp raised its position in shares of II-VI by 9.1% in the 1st quarter. State Street Corp now owns 1,374,859 shares of the scientific and technical instruments company’s stock valued at $49,563,000 after purchasing an additional 114,283 shares during the last quarter. Kornitzer Capital Management Inc. KS purchased a new position in shares of II-VI in the 2nd quarter valued at approximately $2,577,000. Finally, Argent Capital Management LLC purchased a new position in shares of II-VI in the 2nd quarter valued at approximately $1,610,000. 78.03% of the stock is owned by hedge funds and other institutional investors.

II-VI Company Profile

II-VI Incorporated develops and manufactures engineered materials, optoelectronic components and products. The Company has three segments: II-VI Laser Solutions, II-VI Photonics and II-VI Performance Products. The II-VI Laser Solutions segment designs, manufactures and markets optical and electro-optical components and materials sold under the II-VI Infrared brand name and used in carbon dioxide (CO2) lasers, fiber-delivered beam delivery systems and processing tools and direct diode lasers for industrial lasers sold under the II-VI HIGHYAG and II-VI Laser Enterprise brand names.

Get a free copy of the Zacks research report on II-VI (IIVI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for II-VI (NASDAQ:IIVI)

What are top analysts saying about II-VI Incorporated? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for II-VI Incorporated and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit